Skip to main content
Access Resources

MJFF Publications

331 - 340 of 7370 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • OPEN
    Title: Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon Activation
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.jmb.2023.167999
    Citation Count: 8
  • RESTRICTED
    Title: Stability Changes in Fall-Prone Individuals With Parkinson Disease Following Reactive Step Training
    Journal Name: Journal of Neurologic Physical Therapy
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/npt.0000000000000442
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: The Endo-lysosomal System in Parkinson’s Disease: Expanding the Horizon
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140
    Citation Count: 4
  • RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
    Journal Name: Clinical Epidemiology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/clep.s405325
    Citation Count: 0
  • OPEN
    Title: Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.23016
    Citation Count: 1
  • OPEN
    Title: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555
    Citation Count: 3
  • OPEN
    Title: The contributions of mitochondrial and nuclear mitochondrial genetic variation to neuroticism
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-38480-y
    Citation Count: 2
  • OPEN
    Title: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853
    Citation Count: 2
  • RESTRICTED
    Title: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad026
    Best OA location URL:
    Citation Count: 1
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.